Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Surmodics Inc (SRDX)

Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Surmodics Inc 9924 WEST 74TH STREET EDEN PRAIRIE MN 55344 USA

www.surmodics.com P: 952-500-7000 F: 952-500-7001

Description:

Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.'The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.

Key Statistics

Overview:

Market Capitalization, $K 409,997
Enterprise Value, $K 397,987
Shares Outstanding, K 14,236
Annual Sales, $ 132,580 K
Annual Net Income, $ -1,540 K
Last Quarter Sales, $ 30,550 K
Last Quarter Net Income, $ -790 K
EBIT, $ 15,540 K
EBITDA, $ 24,430 K
60-Month Beta 1.01
% of Insider Shareholders 8.90%
% of Institutional Shareholders 96.63%
Float, K 12,969
% Float 91.10%
Short Volume Ratio 0.35

Growth:

1-Year Return 49.77%
3-Year Return -48.74%
5-Year Return -38.37%
5-Year Revenue Growth 62.99%
5-Year Earnings Growth -67.35%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 02/01/24
Latest Earnings Date 04/24/24
Earnings Per Share ttm 0.65
EPS Growth vs. Prev Qtr -100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 12/07/00

SRDX Ratios

Ratio
Price/Earnings ttm 43.40
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 8.06%
Return-on-Assets % 5.11%
Profit Margin % -1.16%
Debt/Equity 0.24
Price/Sales 3.03
Price/Cash Flow 35.27
Price/Book 3.22
Book Value/Share 8.58
Interest Coverage -1.71
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar